Total Payments
$3,439
2024 Payments
$198.32
Companies
38
Transactions
127
Medicare Patients
8,528
Medicare Billing
$2.1M
Payment Breakdown by Category
Food & Beverage$3,311 (96.3%)
Education$127.98 (3.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,311 | 124 | 96.3% |
| Education | $127.98 | 3 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $462.50 | 12 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $322.93 | 17 | $0 (2024) |
| Celgene Corporation | $249.19 | 9 | $0 (2023) |
| Amgen Inc. | $227.78 | 4 | $0 (2022) |
| Daiichi Sankyo Inc. | $218.34 | 9 | $0 (2022) |
| Exelixis Inc. | $194.73 | 5 | $0 (2022) |
| Genentech USA, Inc. | $177.29 | 5 | $0 (2017) |
| Janssen Biotech, Inc. | $157.21 | 9 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $144.64 | 9 | $0 (2019) |
| Seattle Genetics, Inc. | $128.20 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $198.32 | 9 | REVANCE THERAPEUTICS, INC. ($61.09) |
| 2023 | $186.85 | 4 | Karyopharm Therapeutics Inc. ($124.99) |
| 2022 | $570.37 | 11 | Daiichi Sankyo Inc. ($137.29) |
| 2021 | $177.44 | 10 | Novartis Pharmaceuticals Corporation ($93.81) |
| 2020 | $62.30 | 4 | Daiichi Sankyo Inc. ($46.86) |
| 2019 | $350.88 | 18 | E.R. Squibb & Sons, L.L.C. ($106.71) |
| 2018 | $238.44 | 16 | Janssen Biotech, Inc. ($28.35) |
| 2017 | $1,654 | 55 | E.R. Squibb & Sons, L.L.C. ($355.79) |
All Payment Transactions
127 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/03/2024 | Apellis Pharmaceuticals, Inc. | Empaveli (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Hematology | ||||||
| 08/26/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/07/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Education | In-kind items and services | $17.02 | General |
| Category: ONCOLOGY | ||||||
| 06/17/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: IMMUNOLOGY | ||||||
| 06/03/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $27.23 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 04/11/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $33.86 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 04/10/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Oncology | ||||||
| 03/27/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $15.73 | General |
| 02/27/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $23.38 | General |
| Category: Oncology | ||||||
| 07/20/2023 | Janssen Biotech, Inc. | — | Food and Beverage | In-kind items and services | $15.94 | General |
| 05/15/2023 | Emmaus Medical, Inc. | Endari (Drug) | Food and Beverage | In-kind items and services | $29.36 | General |
| Category: Sickle Cell | ||||||
| 04/13/2023 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $16.56 | General |
| Category: Hematology | ||||||
| 03/28/2023 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Oncology | ||||||
| 11/29/2022 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $90.21 | General |
| Category: Oncology | ||||||
| 09/20/2022 | Daiichi Sankyo Inc. | ENHERTU (Drug) | Food and Beverage | In-kind items and services | $129.31 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2022 | Emmaus Medical, Inc. | Endari (Drug) | Food and Beverage | In-kind items and services | $28.69 | General |
| Category: Sickle Cell | ||||||
| 06/14/2022 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | Cash or cash equivalent | $128.47 | General |
| Category: Oncology | ||||||
| 04/22/2022 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: ONCOLOGY | ||||||
| 03/15/2022 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: ONCOLOGY | ||||||
| 03/15/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $4.68 | General |
| Category: Iron Deficiency Anemia | ||||||
| 03/15/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $2.50 | General |
| Category: Iron Deficiency Anemia | ||||||
| 03/15/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $0.80 | General |
| Category: Iron Deficiency Anemia | ||||||
| 03/08/2022 | Epizyme, Inc., | TAZVERIK (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 02/01/2022 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: ONCOLOGY | ||||||
| 11/10/2021 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 1,977 | 72,693 | $2.1M | $538,564 |
| 2022 | 39 | 2,606 | 111,207 | $3.1M | $785,839 |
| 2021 | 37 | 2,107 | 71,001 | $1.6M | $457,500 |
| 2020 | 30 | 1,838 | 35,739 | $806,760 | $319,106 |
Total Patients
8,528
Total Services
290,640
Medicare Billing
$2.1M
Procedure Codes
138
All Medicare Procedures & Services
138 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 14 | 5,000 | $799,990 | $216,857 | 27.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 291 | 781 | $328,983 | $81,598 | 24.8% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2023 | 54 | 53,250 | $185,160 | $46,065 | 24.9% |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | Office | 2023 | 29 | 115 | $169,006 | $40,473 | 23.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 62 | 226 | $104,350 | $26,983 | 25.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 89 | 293 | $73,196 | $19,788 | 27.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 211 | 269 | $80,243 | $19,112 | 23.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 11 | 840 | $56,167 | $15,505 | 27.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 115 | 174 | $39,431 | $10,118 | 25.7% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 65 | 352 | $35,407 | $9,183 | 25.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 41 | 41 | $29,498 | $7,750 | 26.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 352 | 708 | $21,723 | $5,914 | 27.2% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 20 | 78 | $17,704 | $4,646 | 26.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 87 | 367 | $17,483 | $4,331 | 24.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $16,975 | $4,046 | 23.8% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 13 | 60 | $15,794 | $3,939 | 24.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 25 | $14,706 | $3,602 | 24.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 139 | 373 | $8,755 | $2,839 | 32.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 26 | $9,229 | $2,644 | 28.7% |
| 96411 | Administration of additional new drug or substance into vein using push technique | Office | 2023 | 11 | 48 | $9,422 | $2,453 | 26.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 16 | $9,353 | $2,368 | 25.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 21 | 21 | $8,809 | $2,330 | 26.5% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 85 | 259 | $3,598 | $1,629 | 45.3% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 18 | 79 | $5,599 | $1,465 | 26.2% |
| J1756 | Injection, iron sucrose, 1 mg | Office | 2023 | 23 | 7,200 | $6,828 | $1,154 | 16.9% |
About Dr. David Richards, MD
Dr. David Richards, MD is a Hematology & Oncology healthcare provider based in Somerset, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1235129396.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Richards, MD has received a total of $3,439 in payments from pharmaceutical and medical device companies, with $198.32 received in 2024. These payments were reported across 127 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($3,311).
As a Medicare-enrolled provider, Richards has provided services to 8,528 Medicare beneficiaries, totaling 290,640 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 138 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Internal Medicine
- Location Somerset, NJ
- Active Since 10/28/2005
- Last Updated 08/15/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1235129396
Products in Payments
- OPDIVO (Biological) $241.15
- EMPLICITI (Biological) $221.35
- Cabometyx (Drug) $194.73
- Revlimid (Drug) $166.88
- KEYTRUDA (Biological) $130.61
- ENHERTU (Drug) $129.31
- ADCETRIS (Biological) $128.20
- TAZVERIK (Drug) $125.00
- XPOVIO (Drug) $124.99
- Avastin (Biological) $123.59
- TASIGNA (Drug) $107.07
- LUMAKRAS (Drug) $90.21
- SCEMBLIX (Drug) $83.72
- KISQALI (Drug) $76.08
- ZYTIGA (Drug) $70.35
- DARZALEX (Biological) $69.00
- IBRANCE (Drug) $62.89
- Enhertu (Drug) $61.98
- DAXXIFY (Drug) $61.09
- Endari (Drug) $58.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Somerset
Sameer Desai, Md, MD
Hematology & Oncology — Payments: $25,350
Hematology & Oncology $25,350
Marcus Porcelli, Md, MD
Hematology & Oncology — Payments: $5,458
Hematology & Oncology $5,458
Craig Lampert, Md, MD
Hematology & Oncology — Payments: $5,451
Hematology & Oncology $5,451
Robert Fein, Md, MD
Hematology & Oncology — Payments: $4,633
Hematology & Oncology $4,633
Yumi Kim, Md, MD
Hematology & Oncology — Payments: $2,812
Hematology & Oncology $2,812
Dr. N Mullai, Md, MD
Hematology & Oncology — Payments: $175.69
Hematology & Oncology $175.69